Kymab Limited clinical trials
Acquired by Sanofi, Apr 9, 2021 · source ↗
The registry lists 5 studies whose lead sponsor is Kymab Limited. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 3, 2025.
- 5studies on the registry
- 0open to participants now
Before and after it joined Sanofi
- First submitted before Kymab Limited became part of Sanofi
- 4
- First submitted after Kymab Limited became part of Sanofi
- 1
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
What it is testing
The drugs Kymab Limited’s studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.
Studies, none open
- 0 open · 4
All 5 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Over the years
- 117
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Kymab Limited5 studies
Something wrong with this grouping? Tell us on the Sanofi page.
Studies
Recruiting first, then most recently updated. Showing 5 of 5. All Sanofi studies →
- Study Testing Response Effect of KY1005 Against Moderate-to-Severe Atopic Dermatitis, The STREAM-AD StudyCompletedNCT05131477Phase 2
Sponsor listed in the registry: Kymab Limited · First submitted after Kymab Limited became part of Sanofi
- A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced MalignanciesTerminatedNCT03829501Phase 1/2
Sponsor listed in the registry: Kymab Limited · First submitted before Kymab Limited became part of Sanofi
- A Study of KY1005 in Patients With Moderate to Severe Atopic DermatitisCompletedNCT03754309Phase 2
Sponsor listed in the registry: Kymab Limited · First submitted before Kymab Limited became part of Sanofi
- A Study of Subcutaneous KY1005 in Healthy VolunteersCompletedNCT04449939Phase 1
Sponsor listed in the registry: Kymab Limited · First submitted before Kymab Limited became part of Sanofi
- A Study of KY1005 in Healthy VolunteersCompletedNCT03161288Phase 1
Sponsor listed in the registry: Kymab Limited · First submitted before Kymab Limited became part of Sanofi